IBO
IMPACT BIOMEDICAL INC.
Key Financials
Net Income
$-11838000
↑ 52.1%
Revenue
$32000
↓ 36.0%
Operating Income
$-4282000
↑ 85.1%
Total Assets
$17.4M
↓ 14.2%
Shareholders' Equity
$12.6M
↑ 196.1%
EPS (Diluted)
$-0.38
↑ 83.5%
Total Liabilities
$1.9M
↓ 85.8%
Cash & Equivalents
$3000.00
↓ 99.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 5/12/2026 | View on SEC |
| 144 | 4/29/2026 | View on SEC |
| S-8 POS | 4/22/2026 | View on SEC |
| S-8 POS | 4/6/2026 | View on SEC |
| 4 | 3/30/2026 | View on SEC |
| 4 | 3/25/2026 | View on SEC |
| 10-K | 3/11/2026 | View on SEC |
| 8-K | 3/4/2026 | View on SEC |
| 4 | 1/6/2026 | View on SEC |
| DEF 14C | 12/30/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | IBO |
| Company Name | IMPACT BIOMEDICAL INC. |
| CIK | 1834105 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | NYSE |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | 585 232 1500 |